Cas No.: | 219685-50-4 |
pH value: | Corresponds to reference standard: PASS |
Non-reduced CE-SDS: | 98.5% |
SEC-HPLC: | 99.7% |
Isoelectric Point: | Corresponds to reference standard:PASS |
Bacterial Endotoxins Test: | <1 EU/ml |
Exogenous Residual DNA: | <1 pg/mg |
Residual protein A: | <1 ng/mg |
Biological Activity: | Compared with standard, the range of biological activity is 110% |
Osmolality: | Corresponds to reference standard: PASS |
Peptide mapping: | Corresponds to reference standard: PASS |
N-terminal sequence: | Corresponds to reference standard:PASS |
Description: | Eculizumab is a long-acting humanized monoclonal antibody targeted against complement C5 and it is used to treat a number of autoimmune conditions. |